SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in Verastem, Inc.

Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has disclosed a beneficial ownership of 9.99% in Verastem, Inc.'s common stock as of December 31, 2024.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
• The filing reports their beneficial ownership of 4,523,184 shares of Verastem, Inc. common stock.
• This aggregate amount represents 9.99% of Verastem, Inc.'s outstanding common stock.
• The reported shares include 770,601 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• Nantahala Capital Management, LLC is a Massachusetts limited liability company, while Wilmot B. Harkey and Daniel Mack are citizens of the United States.
• The Reporting Persons hold shared voting and shared dispositive power over all 4,523,184 shares.
• BLACKWELL PARTNERS LLC SERIES A, a fund advised by Nantahala, holds more than five percent of the outstanding shares beneficially owned by Nantahala.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral regulatory filing.

Positives

• The disclosure indicates significant institutional investor interest in Verastem, Inc. by Nantahala Capital Management, LLC and its principals.
• The holding of 9.99% suggests a substantial, but passive, investment position.

Negatives

• The document does not contain any negative information regarding Verastem, Inc.'s financial performance or operational status.

Risks

• The document does not explicitly mention any specific risks related to Verastem, Inc.'s operations or financial health, as it is a beneficial ownership report.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This Schedule 13G filing is a standard regulatory disclosure indicating that an investment firm, Nantahala Capital Management, and its principals have acquired a significant, but passive, stake in Verastem, Inc. Such filings are common for institutional investors who hold more than 5% of a company's stock but do not intend to influence or change control of the company. It signals a notable investment by a specialized fund in the biotechnology sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially influencing market perception and liquidity.
• Management: Awareness of a large, passive shareholder, which typically does not seek to influence corporate control.

Key Dates

Keywords

Verastem Inc., Nantahala Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Investment Management, Institutional Investor, Biotechnology, Pharmaceuticals